Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Financing Activities (2020 - 2025)

BioAtla (BCAB) has 6 years of Cash from Financing Activities data on record, last reported at -$6000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 57.14% year-over-year to -$6000.0; the TTM value through Sep 2025 reached $8.9 million, up 2700.0%, while the annual FY2024 figure was $9.5 million, 12251.95% up from the prior year.
  • Cash from Financing Activities reached -$6000.0 in Q3 2025 per BCAB's latest filing, up from -$36000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $75.1 million in Q3 2021 and bottomed at -$3.9 million in Q4 2021.
  • Average Cash from Financing Activities over 5 years is $7.4 million, with a median of -$14000.0 recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: surged 7726.05% in 2024, then tumbled 2938.46% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$3.9 million in 2021, then soared by 1680.48% to $61.8 million in 2022, then plummeted by 99.81% to $119000.0 in 2023, then soared by 7726.05% to $9.3 million in 2024, then crashed by 100.06% to -$6000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$6000.0 in Q3 2025, -$36000.0 in Q2 2025, and -$395000.0 in Q1 2025.